• Language: English
    • Italiano Italiano
    • English English

CNCCS

MENU
  • Home
  • Chemical Compounds
    • Compound Collection
    • Our Laboratories
  • Centre for rare diseases
    • Research Areas
    • Rare Diseases
    • Neglected and Poverty Diseases
  • Bioeconomy
    • Edition 2014
    • Edition 2013
    • Edition 2012
    • Edition 2011
  • Media
    • Press Review
    • Video Gallery
  • Contact Us
  • Job Opportunities
piero di lorenzo

(Italiano) Piero Di Lorenzo firma il progetto Pronat con CNR e Unitus

30 June 2016 Comments Off on (Italiano) Piero Di Lorenzo firma il progetto Pronat con CNR e Unitus news  Like

Sorry, this entry is only available in Italian.

 Like news (Italiano) Piero Di Lorenzo firma il progetto Pronat con CNR e Unitus

About the Author: cnccs

Comments are closed.

Recent Posts

  • Covid, Minister Speranza to the Washington Post: “The Oxford-Pomezia vaccine will arrive before the others”
  • Visit to IRBM. Minister Speranza: “Italy, a key role to have the vaccine”
  • Speranza visits the Italian company that is working on the vaccine
  • Coronavirus. Pomezia vaccine, first trial results in 10 days. The USA and China are also competing
  • The company from Pomezia (Rome) is a forerunner for vaccines: “Production has started, we will be ready in September”

Contact Us

Fax: +39.06.91093654
Mail: info@cnccs

CNCCS Scarl
Collection of National Chemical Compounds and Screening Center
Via Pontina km 30,600 – 00040 Pomezia (RM)

News

  • Covid, Minister Speranza to the Washington Post: “The Oxford-Pomezia vaccine will arrive before the others”
  • Visit to IRBM. Minister Speranza: “Italy, a key role to have the vaccine”
  • Speranza visits the Italian company that is working on the vaccine
  • Coronavirus. Pomezia vaccine, first trial results in 10 days. The USA and China are also competing

Partners